MU
38
-4
ACN
65
16
SNA
75
3
COP
54
-2
CSX
65
-3
NSC
62
-3
TAP
60
2
GILD
60
-3
TSCO
51
-2
PPG
60
-4
BWA
55
2
PLD
48
-2
MOS
38
-12
FSLR
40
-3
GOOG
79
2
AME
75
6
QCOM
57
-3
HCA
53
-2
AEE
63
-3
MMM
37
-7
MU
38
-4
ACN
65
16
SNA
75
3
COP
54
-2
CSX
65
-3
NSC
62
-3
TAP
60
2
GILD
60
-3
TSCO
51
-2
PPG
60
-4
BWA
55
2
PLD
48
-2
MOS
38
-12
FSLR
40
-3
GOOG
79
2
AME
75
6
QCOM
57
-3
HCA
53
-2
AEE
63
-3
MMM
37
-7
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
34

VYGR
Voyager Therapeutics

Last Price:
6.69
Seasonality Move:
-0.12%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Voyager Therapeutics Price Quote

$6.69
-0.14 (-2.05%)
(Updated: November 13, 2024 at 5:55 PM ET)

Voyager Therapeutics Key Stats

Sell
34
Voyager Therapeutics (VYGR) is a Sell
Day range:
$6.74 - $7.05
52-week range:
$5.71 - $11.72
Dividend yield:
0%
P/E ratio:
2.30
P/S ratio:
2.48
P/B ratio:
1.11%
Volume:
546.3K
Avg. volume:
658.8K
1-year change:
7.56%
Market cap:
$372.5M
Revenue:
$250M
EPS:
$0.22

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

  • What Is Voyager Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 5.09%
  • What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.6M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $114.2M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$263.5M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 3.5%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 2.42%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 3.5%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.7%
Revenue: 509.48% 210.88%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.33
Upside from Last Price: 153.78%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    50.1M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    3M VYGR shares are owned by insiders